A clinical trial of alpha-6-deoxy oxytetracycline (doxycycline) in the treatment of pyogenic infections in cases of diabetes mellitus.
D000293:Adolescent; D000328:Adult; D001424:Bacterial Infections / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D048909:Diabetes Complications; D004318:Doxycycline / Q000009:adverse effects / Q000627:therapeutic use; D004756:Enterobacteriaceae Infections / Q000188:drug therapy; D004926:Escherichia coli; D005260:Female; D006801:Humans; D008297:Male; D008826:Microbial Sensitivity Tests; D008875:Middle Aged; D010118:Oxytetracycline / Q000627:therapeutic use*; D012874:Skin Diseases, Infectious / Q000188:drug therapy; D013203:Staphylococcal Infections / Q000188:drug therapy; D013210:Staphylococcus / Q000187:drug effects; D013290:Streptococcal Infections / Q000188:drug therapy; D013297:Streptococcus pyogenes / Q000187:drug effects; D013896:Thoracic Diseases / Q000188:drug therapy; D013997:Time Factors
D004318:Doxycycline; D010118:Oxytetracycline